Skip to content
  • Wednesday, 14 October 2026
  • 12:46 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FDA Approves Zanvastro as the First Disease-Modifying Treatment for Rare Alexander Disease
Neuroscience & Brain Research

FDA Approves Zanvastro as the First Disease-Modifying Treatment for Rare Alexander Disease

Rifan Muazin Oct 14, 2026 0

The U.S. Food and Drug Administration (FDA) has officially granted approval to Zanvastro, marking a watershed moment in medical history…

Read More
Diabetes to MASH: the specimens behind GLP-1’s widening rosterTWiV 1286: Clinical update with Dr. Daniel GriffinFrom Animal Crackers to the Edge of Space: How a $100 Pocket-Sized Detector is Democratizing Particle PhysicsUnlocking the Neural Code of Exhaustion: International Study Pinpoints Brain Cells That Drive the Irresistible Urge to Sleep
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning PractitionersScience News: A Century of Commitment to Scientific Literacy and Public EngagementPfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
Lana Keisha Oct 14, 2026
Data Science & Bioinformatics
Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning Practitioners
Evan Lee Salim Oct 14, 2026
Environmental & Analytical Chemistry
Science News: A Century of Commitment to Scientific Literacy and Public Engagement
Abdurrohim Arsyad Oct 14, 2026
Pharmaceutical R&D
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Teuku Ryan Oct 14, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ